Aterian, Inc. (NASDAQ:ATER – Get Free Report) was the target of a large growth in short interest during the month of March. As of March 31st, there was short interest totaling 264,469 shares, a growth of 57.7% from the March 15th total of 167,750 shares. Approximately 3.0% of the company’s stock are sold short. Based on an average daily trading volume, of 38,547 shares, the days-to-cover ratio is presently 6.9 days.
Wall Street Analyst Weigh In
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Aterian in a research report on Wednesday, January 21st. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Reduce”.
Read Our Latest Stock Report on ATER
Institutional Trading of Aterian
Aterian Trading Up 0.9%
Shares of NASDAQ:ATER opened at $0.68 on Tuesday. The company has a market capitalization of $7.36 million, a PE ratio of -0.28 and a beta of 0.04. Aterian has a twelve month low of $0.52 and a twelve month high of $2.19. The firm has a 50 day simple moving average of $0.61 and a 200-day simple moving average of $0.76.
Aterian Company Profile
Aterian Inc is a technology-driven consumer products company that leverages artificial intelligence and machine learning to develop, source and market branded household, health and personal care products. Through its proprietary data analytics platform, Aterian identifies emerging trends, forecasts demand and optimizes product selection, pricing and distribution. The company maintains a vertically integrated supply chain, overseeing manufacturing partnerships and logistics to support rapid product development and market entry.
Aterian’s portfolio spans a range of categories including home and kitchen, health and wellness, baby care, beauty tools and electronics accessories.
Featured Stories
Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.
